Michelle M. OvanesianAssociateProskauer Rose LLPWebsitewww.proskauer.comConnectEmail310.284.5620 Professional Biography Michelle Ovanesian is an associate in the Litigation Department and a member of the Firm’s Intellectual Property Group and Life Sciences Patent practice. More Legal and Business Bylines From Michelle M. Ovanesian California Court Holds Defendants Liable for Fraudulent Wire Transfer - (Posted On Tuesday, June 03, 2025) Employee Mobility and Trade Secrets in the Golden Era of Life Sciences Innovation - (Posted On Tuesday, May 21, 2024) Alleged Theft of Drug Pricing Trade Secrets Could Cost Both Victim and Thief - (Posted On Tuesday, November 28, 2023) FTC Continues to Stake Out Role as Key AI Regulator - (Posted On Tuesday, September 26, 2023) Recent Partial Dismissal of Illinois Biometric Privacy Suit May Add Some Weight to the Scale on the Side of Defendants - (Posted On Tuesday, September 05, 2023) SolarWinds: A Lesson on How Companies Victimized by Data Breaches Can Quickly Become the Target of Litigation and Regulatory Investigations - (Posted On Wednesday, November 16, 2022) When Nondisclosure Agreements and Pharmaceutical Trade Secrets Intersect - (Posted On Wednesday, December 15, 2021) President Biden’s Executive Order on Competition Signals Potential Changes Affecting Patents in the Healthcare Sector - (Posted On Wednesday, July 28, 2021) Bioplastics: Snickers® Candy Bars Have It Wrapped Up - (Posted On Wednesday, April 21, 2021) COVID-19 “Not a Golden Ticket” to Avoid Discovery Obligations - (Posted On Monday, February 01, 2021) Pagination Page 1 Next page Next › Current Legal Analysis August 2025 ESG Policy Update—Australia by: Jim Bulling , Clive Cachia Avoiding Legal Pitfalls When Employees Are Arrested Off Duty by: Sarah W. Walsh Three Steps to Protect Your Insurance Program During National Preparedness Month by: Katherine J. Henry , Aaron J. Campbell Mintz IRA Update — 340B Roundup: CMS Proposes Steeper OPPS Clawbacks, Launches Drug Cost Survey with Public Comment by: Lauren M. Moldawer , Xavier G. Hardy AI Vendor Liability Squeeze: Courts Expand Accountability While Contracts Shift Risk by: Jason M. Loring , Lara Sevener HHS Announces Release of MAHA Strategy by: James V. Aidala , Lisa R. Burchi Don’t Fall Behind: The CMMC Final Rule to Update the DFARS is Here! by: Townsend L. Bourne Implications for ECI Risk in Debt Investments - IRS Private Letter Ruling 202536015 by: Pallav Raghuvanshi WashU Law’s Bold Bid to Become the Global Leader in Legal AI by: Eliya France Nasdaq Proposes to Allow Trading of Tokenized Securities by: Wai L Choy , Louis Rambo Five Takeaways from the FTC’s Decision to Abandon the Noncompete Rule by: Taylor Appling , Benjamin R. Dryden AI Chatbots in the Medical Field: Healthcare Hero or HIPAA Nightmare? by: Amy Hill Mintz IRA Update — Still Undefeated: Government Notches Three More Victories in Negotiation Program Lawsuits by: Theresa C. Carnegie , Mitchell J. Clough The Washington Supreme Court’s Decision in Branson v. Washington Fine Wine & Spirits LLC and Its Significance for Employers by: Robert T. Dumbacher , Meredith Gregston Mintz IRA Update — PhRMA’s 2025 Policy Agenda and the Industry’s Crossroads with the IRA and Drug Pricing Reform by: Theresa C. Carnegie , Ayaz R. Shaikh Upcoming Events Sep 18 2025 Workplace Horizons Extension: Chicago Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Oct 20-21 2025 Intellectual Property Law Institute 2025 - California Oct 21-22 2025 2025 Proxy Disclosure & 22nd Annual Executive Compensation Conferences Print
